Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check15 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 13, 2025.SummaryDifference1.0%
- Check22 days agoNo Change Detected
- Check59 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check66 days agoChange DetectedThe webpage has updated its date reference from November 21, 2024, to February 13, 2025.SummaryDifference0.9%
- Check73 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check80 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.